Acalka (Potassium Citrate)

Acalka is a pharmaceutical product containing potassium citrate, widely prescribed for the prevention and treatment of kidney stones and metabolic acidosis associated with renal diseases. The brand is deeply associated with European pharmaceutical excellence, specifically within the urological health sector.

Manufacturing for the Spanish and European markets is primarily conducted in Spain at facilities owned by Casen Recordati. As a pharmaceutical agent, its production follows strict international standards. The brand's ownership has transitioned through corporate acquisitions, currently sitting under the umbrella of an international specialty pharmaceutical group that operates across more than 150 countries worldwide.